Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
301.6 USD | +1.25% | -2.53% | +6.55% |
Apr. 30 | ICON Prices $2 Billion Debt Offering | MT |
Apr. 30 | ICON Public Limited Company Announces Pricing of USD 2 Billion Notes | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 30.49 times its estimated earnings per share for the ongoing year.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Biotechnology & Medical Research
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+6.55% | 24.63B | B- | ||
+0.67% | 42.19B | B | ||
+44.30% | 40.15B | A | ||
-6.20% | 28.31B | C | ||
-21.66% | 18.2B | B | ||
+29.96% | 12.01B | C+ | ||
-1.57% | 11.76B | C+ | ||
+16.03% | 10.4B | B+ | ||
-4.80% | 9.94B | B+ | ||
-4.38% | 9.39B | A |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- ICLR Stock
- Ratings ICON Public Limited Company